Targeted serum glycoproteomics for the discovery of lung cancer-associated glycosylation disorders using lectin-coupled ProteinChip arrays

Proteomics

Volumn 9, Issue 8, 2009, Pages 2182-2192

  Ueda, Koji ^a   Fukase, Yu ^b   Katagiri, Toyomasa ^a   Ishikawa, Nobuhisa ^a   Irie, Shinji ^c   Sato, Taka Aki ^c   Ito, Hiroyuki ^d   Nakayama, Haruhiko ^d   Miyagi, Yohei ^d   Tsuchiya, Eiju ^d   Kohno, Nobuoki ^e   Shiwa, Mieko ^b   Nakamura, Yusuke ^a   Daigo, Yataro ^a  

^a THE UNIVERSITY OF TOKYO   (Japan)

^b Yokohama Laboratory   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d KANAGAWA CANCER CENTER   (Japan)

^e HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Biomarker; Glycoproteomics; Lung cancer; SELDI TOF MS; Sialic acid

Indexed keywords

APOLIPOPROTEIN C3; BETA N ACETYLGALACTOSAMINIDASE; GLYCAN; GLYCOPROTEIN; JACALIN; LECTIN; N ACETYLNEURAMINIC ACID; SIALIDASE;

ADULT; ARTICLE; CANCER PATIENT; CANCER STAGING; CARBOHYDRATE ANALYSIS; CONTROLLED STUDY; FEMALE; GLYCOSYLATION; HUMAN; LUNG ADENOCARCINOMA; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN ISOLATION; PROTEIN MICROARRAY; PROTEIN PURIFICATION; PROTEIN STRUCTURE; PROTEOMICS; SIALYLATION; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY;

ADENOCARCINOMA; AGED; APOLIPOPROTEIN C-III; FEMALE; GLYCOSYLATION; HUMANS; LECTINS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROTEIN ARRAY ANALYSIS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TUMOR MARKERS, BIOLOGICAL;

EID: 65349180162     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.200800374     Document Type: Article

References (32)

1. Hoffman, P. C., Mauer, A. M., Vokes, E. E., Lung cancer. Lancet 2000, 355, 479-485.
2. Tarro, G., Perna, A., Esposito, C., Early diagnosis of lung cancer by detection of tumor liberated protein. J. Cell. Physiol. 2005, 203, 1-5.
3. Gutman, S., Kessler, L. G., The US Food and Drug Administration perspective on cancer biomarker development. Nat. Rev. Cancer 2006, 6, 565-571.
4. Bertozzi, C. R., Kiessling, L. L., Chemical glycobiology. Science 2001, 291, 2357-2364.
5. Rudd, P. M., Elliott, T., Cresswell, P., Wilson, I. A., Dwek, R. A., Glycosylation and the immune system. Science 2001, 291, 2370-2376.
6. Gewinner, C., Hart, G., Zachara, N., Cole, R. et al., The coactivator of transcription CREB-binding protein interacts preferentially with the glycosylated form of Stat5. J. Biol. Chem. 2004, 279, 3563-3572.
7. Alikhani, Z., Alikhani, M., Boyd, C. M., Nagao, K. et al., Advanced glycation end products enhance expression of proapoptotic genes and stimulate fibroblast apoptosis through cytoplasmic and mitochondrial pathways. J. Biol. Chem. 2005, 280, 12087-12095.
8. Phan, U. T., Waldron, T. T., Springer, T. A., Remodeling of the lectin-EGF-like domain interface in P- and L-selectin increases adhesiveness and shear resistance under hydrodynamic force. Nat. Immunol. 2006, 7, 883-889.
9. Partridge, E. A., Le Roy, C., Di Guglielmo, G. M., Pawling, J. et al., Regulation of cytokine receptors by Golgi N-glycan processing and endocytosis. Science 2004, 306, 120-124.
10. Hakomori, S., Tumor-associated carbohydrate antigens. Annu. Rev. Immunol. 1984, 2, 103-126.
11. Hakomori, S., Aberrant glycosylation in cancer cell membranes as focused on glycolipids: Overview and perspectives. Cancer Res. 1985, 45, 2405-2414.
12. Hakomori, S., Kannagi, R., Glycosphingolipids as tumorassociated and differentiation markers. J. Natl. Cancer Inst. 1983, 71, 231-251.
13. Dall'Olio, F., Chiricolo, M., Mariani, E., Facchini, A., Biosynthesis of the cancer-related sialyl-7alpha;2,6-lactosaminyl epitope in colon cancer cell lines expressing β-galactoside α2,6-sialyltransferase under a constitutive promoter. Eur. J. Biochem. 2001, 268, 5876-5884.
14. Hollingsworth, M. A., Swanson, B. J., Mucins in cancer: Protection and control of the cell surface. Nat. Rev. Cancer 2004, 4, 45-60.
15. Schietinger, A., Philip, M., Yoshida, B. A., Azadi, P. et al., A mutant chaperone converts a wild-type protein into a tumorspecific antigen. Science 2006, 314, 304-308.
16. Noda, K., Miyoshi, E., Uozumi, N., Yanagidani, S. et al., Gene expression of α1-6 fucosyltransferase in human hepatoma tissues: A possible implication for increased fucosylation of α-fetoprotein. Hepatology 1998, 28, 944-952.
17. Li, D., Mallory, T., Satomura, S., AFP-L3: A new generation of tumor marker for hepatocellular carcinoma. Clin. Chim. Acta 2001, 313, 15-19.
18. Okuyama, N., Ide, Y., Nakano, M., Nakagawa, T. et al., Fucosylated haptoglobin is a novel marker for pancreatic cancer: A detailed analysis of the oligosaccharide structure and a possible mechanism for fucosylation. Int. J. Cancer 2006, 118, 2803-2808.
19. Ueda, K., Katagiri, T., Shimada, T., Irie, S. et al., Comparative profiling of serum glycoproteome by sequential purification of glycoproteins and 2-nitrobenzensulfenyl (NBS) stable isotope labeling: A new approach for the novel biomarker discovery for cancer. J. Proteome Res. 2007, 6, 3475-3483.
20. Miyazaki, K., Ohmori, K., Izawa, M., Koike, T. et al., Loss of disialyl Lewis(a), the ligand for lymphocyte inhibitory receptor sialic acid-binding immunoglobulin-like lectin-7 (Siglec-7) associated with increased sialyl Lewis(a) expression on human colon cancers. Cancer Res. 2004, 64, 4498-4505.
21. Izawa, M., Kumamoto, K., Mitsuoka, C., Kanamori, C. et al., Expression of sialyl 6-sulfo Lewis X is inversely correlated with conventional sialyl Lewis X expression in human colorectal cancer. Cancer Res. 2000, 60, 1410-1416.
22. Petricoin, E. F., Belluco, C., Araujo, R. P., Liotta, L. A., The blood peptidome: A higher dimension of information content for cancer biomarker discovery. Nat. Rev. Cancer 2006, 6, 961-967.
23. Rosty, C., Christa, L., Kuzdzal, S., Baldwin, W. M. et al., Identification of hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein I as a biomarker for pancreatic ductal adenocarcinoma by protein biochip technology. Cancer Res. 2002, 62, 1868-1875.
24. Roghani, A., Zannis, V. I., Mutagenesis of the glycosylation site of human ApoCIII. O-linked glycosylation is not required for ApoCIII secretion and lipid binding. J. Biol. Chem. 1988, 263, 17925-17932.
25. Harvey, D. J., Matrix-assisted laser desorption/ionization mass spectrometry of carbohydrates. Mass Spectrom. Rev. 1999, 18, 349-450.
26. Hiki, Y., Tanaka, A., Kokubo, T., Iwase, H. et al., Analyses of IgA1 hinge glycopeptides in IgA nephropathy by matrixassisted laser desorption/ionization time-of-flight mass spectrometry. J. Am. Soc. Nephrol. 1998, 9, 577-582.
27. Keller, B. O., Li, L., Three-layer matrix/sample preparation method for MALDI MS analysis of low nanomolar protein samples. J. Am. Soc. Mass Spectrom. 2006, 17, 780-785.
28. Laremore, T. N., Zhang, F., Linhardt, R. J., Ionic liquid matrix for direct UV-MALDI-TOF-MS analysis of dermatan sulfate and chondroitin sulfate oligosaccharides. Anal. Chem. 2007, 79, 1604-1610.
29. Bourne, Y., Astoul, C. H., Zamboni, V., Peumans, W. J. et al., Structural basis for the unusual carbohydrate-binding specificity of jacalin towards galactose and mannose. Biochem. J. 2002, 364, 173-180.
30. Shibuya, N., Goldstein, I. J., Broekaert, W. F., Nsimba-Lubaki, M. et al., The elderberry (Sambucus nigra L.) bark lectin recognizes the Neu5Ac(7alpha;2-6)Gal/GalNAc sequence. J. Biol. Chem. 1987, 262, 1596-1601.
31. Takahashi, K., Hiki, Y., Odani, H., Shimozato, S. et al., Structural analyses of O-glycan sugar chains on IgA1 hinge region using SELDI-TOF MS with various lectins. Biochem. Biophys. Res. Commun. 2006, 350, 580-587.
32. Senda, M., Ito, A., Tsuchida, A., Hagiwara, T. et al., Identification and expression of a sialyltransferase responsible for the synthesis of disialylgalactosylgloboside in normal and malignant kidney cells: Downregulation of ST6GalNAc VI in renal cancers. Biochem. J. 2007, 402, 459-470.